Ann Lab Med.  2014 Jan;34(1):60-63. 10.3343/alm.2014.34.1.60.

Four Cases of Chronic Myelogenous Leukemia in Mixed Phenotype Blast Phase at Initial Presentation Mimicking Mixed Phenotype Acute Leukemia with t(9;22)

Affiliations
  • 1Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. yonggoo@catholic.ac.kr
  • 2Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 3Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract

No abstract available.


MeSH Terms

Acute Disease
Child
Chromosomes, Human, Pair 22
Chromosomes, Human, Pair 9
Female
Fusion Proteins, bcr-abl/genetics
Humans
In Situ Hybridization, Fluorescence
Leukemia/*genetics/pathology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*genetics/pathology
Male
Middle Aged
Phenotype
*Translocation, Genetic
Fusion Proteins, bcr-abl

Figure

  • Fig. 1 Interphase FISH results of case 2. (A) FISH analysis using a BCR/ABL1 Dual color, Dual fusion Translocation Probe, which showed a green signal (native BCR), a red signal (native ABL1), a fused signal, and a smaller green signal, indicating BCR-ABL1 and a loss of ABL1 in neutrophils as well as blasts: nuc ish(ABL1X2),(BCRX3),(ABL1 con BCRX1)[390/400]. (B) FISH analysis using BCR/ABL1 extra signal (ES) Dual Color Translocation Probe, which revealed a green signal (native BCR), a red signal (native ABL1), and a fused signal without a smaller red signal (ES) in neutrophils as well as blasts. The absence of the smaller red signal indicates the loss of ABL1. While using BCR/ABL1 ES probe, if there is no loss of ABL1, a fusion signal and a smaller red extra signal indicate major BCR-ABL1, and 2 fusion signals indicate minor BCR-ABL1. The results of case 2 indicate major BCR-ABL1: nuc ish(ABL1X2),(BCRX2),(ABL1 con BCRX1)[390/400].


Cited by  1 articles

Acute megakaryoblastic blast crisis as a presentation manifestation of chronic myelogenous leukemia
Jenna B Bhattacharya, Richa Gupta, Amit Samadhiya
Blood Res. 2017;52(2):137-139.    doi: 10.5045/br.2017.52.2.137.


Reference

1. Keung YK, Beaty M, Powell BL, Molnar I, Buss D, Pettenati M. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature. Leuk Res. 2004; 28:579–586. PMID: 15120934.
Article
2. Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med. 1988; 319:990–998. PMID: 3047582.
Article
3. Specchia G, Mininni D, Guerrasio A, Palumbo G, Pastore D, Liso V. Ph positive acute lymphoblastic leukemia in adults: molecular and clinical studies. Leuk Lymphoma. 1995; 18(Suppl 1):37–42. PMID: 7496353.
Article
4. Borowitz MJ, Béné MC, Harris NL, Porwit A, Matutes E. Acute leukaemias of ambiguous lineage. In : Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC;2008. p. 150–155.
5. Vardiman JW, Melo JV, Baccarani M, Thiele J. Chronic myelogenous leukaemia, BCR-ABL1 positive. In : Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC;2008. p. 32–37.
6. Larson RS, Wolff SN. Chronic myeloid leukemia. In : Lee GR, Foerster J, Lukens J, Paraskeras F, Greer JP, Rodgers GM, editors. Wintrobe's clinical hematology. 10th ed. Baltimore: Williams & Wilkin's;1999. p. 2342–2373.
7. Yen CC, Liu JH, Wang WS, Fan FS, Chiou TJ, Tai CJ, et al. Immunophenotypic and genotypic characteristics of chronic myelogenous leukemia in blast crisis. Zhonghua Yi Xue Za Zhi. 2000; 63:785–791. PMID: 11155753.
8. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010; 115:453–474. PMID: 19880497.
Article
9. Kim DW, Banavali SD, Bunworasate U, Goh YT, Ganly P, Huang H, et al. Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy era. Leuk Res. 2010; 34:1459–1471. PMID: 20430443.
Article
10. Kobayashi S, Kimura F, Ikeda T, Osawa Y, Torikai H, Kobayashi A, et al. BCR-ABL promotes neutrophil differentiation in the chronic phase of chronic myeloid leukemia by downregulating c-Jun expression. Leukemia. 2009; 23:1622–1627. PMID: 19357699.
Article
11. Lee W, Kim Y, Han K. Eosinophils and basophils carry the fused BCR/ABL gene in chronic myelogenous leukemia: direct fluorescence in situ hybridization analysis on blood smears. Acta Haematol. 1998; 100:106–109. PMID: 9792946.
12. Anastasi J, Feng J, Dickstein JI, Le Beau MM, Rubin CM, Larson RA, et al. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs. Ph+ acute lymphoblastic leukemia. Leukemia. 1996; 10:795–802. PMID: 8656674.
13. Hehlmann R. How I treat CML blast crisis. Blood. 2012; 120:737–747. PMID: 22653972.
Article
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr